XM tidak menyediakan perkhidmatan kepada penduduk Amerika Syarikat.

Poison pills will hurt Seven & i and Japan



<html xmlns="http://www.w3.org/1999/xhtml"><head><title>RPT-BREAKINGVIEWS-Poison pills will hurt Seven & i and Japan</title></head><body>

The authors are Reuters Breakingviews columnists. The opinions expressed are their own. Refiles to fix typo in fourth paragraph.

By Una Galani and Anshuman Daga

MUMBAI, Aug 28 (Reuters Breakingviews) -An iconic company appears to be failing an acid test on Japan Inc reforms. Seven & i 3382.T is seeking a higher level of government protection barely a week after the $38 billion company confirmed Canada's Alimentation Couche-Tard ATD.TO had made a preliminary takeover offer. It's a reflex reaction that an administration trying to shake off three decades of stagnation and promote economic growth needs to avoid.

There are many reasons Tokyo should resist granting this poison pill of sorts. The owner of 7-Eleven convenience stores wants a status that would require any entity taking a more than 10% stake in the company to notify the government beforehand, Bloomberg reported on Tuesday citing unnamed sources. That would effectively prevent a dawn raid on its shares.

The most-protected status is assigned to a wide range of more obviously sensitive companies including Toyota Motor 7203.T, SoftBank Group 9984.T and chipmakers Tokyo Electron and Renesas Electronics 6723.T, per a list updated in 2021. The designation requires a buyer to make greater disclosures but doesn't necessarily prevent a foreign takeover. IT specialist Fuji Soft 9749.T has it and is under a tender offer from U.S. private equity firm KKR KKR.N, for example. Awarding the status, especially after a bidder has already shown interest, would, however, take some fairness and heat out of a value-creation process for a badly underperforming company. It also would be hard to justify putting a retail company in that category.

Japan's foreign investment regime is supposed to offer buyers predictability about the process they will face. Tokyo would in any event need to clear a deal if one is agreed. Acting earlier than it needs to would undermine the drive by the Ministry of Trade, Economy and Industry to force companies to focus on shareholder returns and properly consider bona fide offers. Other Japanese companies are, by contrast, starting to shed various M&A defences.

Ultimately, fewer bidders for Seven & i may emerge if the government changes the company's status while it is in play. Japanese trading giants have been doubling down on food businesses as they seek to reduce their heavy exposure to commodities. Mitsui for example, already owns 2% of the target. Itochu 8001.T in 2020 acquired FamilyMart, a rival Japanese convenience store franchise, while telecoms carrier KDDI 9433.T took private another, Lawson, this year. Yet it was an approach from an outsider, Couche-Tard, that has given Seven & i's shares an 18% bump, and multiple bankers have told Breakingviews that foreign private equity firms are now sizing up the opportunity.

The best course for the government is to ignore Seven & i's request, wait on the sidelines and ensure a fair process.

Follow @ugalani and @anshumandaga on X


CONTEXT NEWS

Seven & i wants the Japanese government to require prior notification of any purchase of its shares above 10%, Bloomberg News reported on Aug. 27, citing people familiar with the matter.

The Japanese operator of 7-Eleven stores has applied to upgrade its "non-core" company status to "core" under the Foreign Exchange and Foreign Trade Act, it added.

The company's shares fell 2% in early trade on Aug. 28 to 2,080 yen, 18% above their price on Aug. 16, the last trading day before it confirmed a preliminary takeover offer from Canada's Alimentation Couche-Tard.


Graphic: Seven & i's share ownership is fragmented https://reut.rs/3XmJG0m


Editing by Antony Currie, Ujjaini Dutta and Aditya Srivastav

</body></html>

Penafian: Entiti XM Group menyediakan perkhidmatan pelaksanaan sahaja dan akses ke Kemudahan Dagangan Atas Talian, yang membolehkan sesorang melihat dan/atau menggunakan kandungan yang ada di dalam atau melalui laman web, tidak bertujuan untuk mengubah atau memperluas, juga tidak mengubah atau mengembangkannya. Akses dan penggunaan tersebut tertakluk kepada: (i) Terma dan Syarat; (ii) Amaran Risiko; dan Penafian Penuh. Oleh itu, kandungan sedemikian disediakan tidak lebih dari sekadar maklumat umum. Terutamanya, perlu diketahui bahawa kandungan Kemudahan Dagangan Atas Talian bukan permintaan, atau tawaran untuk melakukan transaksi dalam pasaran kewangan. Berdagang dalam mana-mana pasaran kewangan melibatkan tahap risiko yang besar terhadap modal anda.

Semua bahan yang diterbitkan di Kemudahan Dagangan Atas Talian kami bertujuan hanya untuk tujuan pendidikan/maklumat dan tidak mengandungi – dan tidak boleh dianggap mengandungi nasihat kewangan, cukai pelaburan atau dagangan dan cadangan, atau rekod harga dagangan kami, atau tawaran, atau permintaan untuk suatu transaksi dalam sebarang instrumen kewangan atau promosi kewangan yang tidak diminta kepada anda.

Sebarang kandungan pihak ketiga serta kandungan yang disediakan oleh XM, seperti pendapat, berita, penyelidikan, analisis, harga, maklumat lain atau pautan ke laman web pihak ketiga yang terdapat dalam laman web ini disediakan berdasarkan "seadanya" sebagai ulasan pasaran umum dan bukanlah nasihat pelaburan. Sesuai dengan apa-apa kandungan yang ditafsir sebagai penyelidikan pelaburan, anda mestilah ambil perhatian dan menerima bahawa kandungan tersebut tidak bertujuan dan tidak sediakan berdasarkan keperluan undang-undang yang direka untuk mempromosikan penyelidikan pelaburan bebas dan oleh itu, ia dianggap sebagai komunikasi pemasaran di bawah peraturan dan undang-undang yang berkaitan. SIla pastikan bahawa anda telah membaca dan memahami Notifikasi mengenai Penyelidikan Pelaburan Bukan Bebas dan Amaran Risiko mengenai maklumat di atas yang boleh diakses di sini.

Amaran Risiko: Modal anda dalam risiko. Produk yang berleveraj mungkin tidak sesuai untuk semua individu. Sila pertimbangkan Pendedahan Risiko kami.